Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

NCT02338037 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Malignant Neoplasm in the Adult Brain
Primary Brain Tumor

Interventions

PROCEDURE: Therapeutic Conventional Surgery
PROCEDURE: Biopsy
DRUG: Eribulin Mesylate
PROCEDURE: Microdialysis
OTHER: Pharmacological Study

Sponsor

City of Hope Medical Center

Collaborators

[object Object]
[object Object]